Stem cells may be the next frontier for retinal disease

Veritti, Daniele; Sarao, Valentina
June 2011
Ocular Surgery News Europe;Jun2011, Vol. 22 Issue 6, p24
The article reports on the potential treatments offered by stem cells with differing risks and benefits in 2011. According to research, stem cells have the potential to be a future option in treating ocular conditions like age-related macular degeneration and proliferative diabetic retinopathy. The author adds that stem cells are categorized as parthenogenetic stem cells (hpSCs), induced pluripotent stem cells (iPSCs), adult stem cells (adultSCs) and human embryonic stem cells (hESCs).


Related Articles

  • Sources of retinal pigment epithelium (RPE) for replacement therapy. E Lee // British Journal of Ophthalmology;Apr2011, Vol. 95 Issue 4, p445 

    Stem cells, with their capacity to regenerate and replace diseased tissues, have recently been proposed as having great potential in the treatment of age-related macular degeneration (AMD). A stem cell therapeutic approach could operate to replace either the retinal pigment epithelium (RPE), the...

  • Stem cell progress. Coghlan, Andy // New Scientist;1/28/2012, Vol. 213 Issue 2849, p7 

    The article discusses a report published in "The Lancet" by scientist Robert Lanza and colleagues that found that the vision of patients with retinal degradation improved after treatment with an injection of human embryonic stem cells.

  • Trends in Treatment of Diabetic Macular Edema. Ciulla, Thomas A. // Review of Ophthalmology;Feb2002, Vol. 9 Issue 2, p92 

    Evaluates the trends in the treatment of diabetic retinopathy and macular edema in the United States. Control of the systemic development of diabetic retinopathy; Mechanism of laser photocoagulation; Development of pharmacologic therapies.

  • Supplements, Lifestyle and AMD: What We Know Today. Singh, Christopher N.; Tewari, Asheesh // Review of Ophthalmology;Oct2009, Vol. 16 Issue 10, p55 

    The article offers information on treatment of age-related macular degeneration (AMD). The article discusses the Age-Related Eye Disease Study (AREDS), a study on the natural history high-dose vitamins in AMD which suggests that supplements such as omega-3 long-chain polyunsaturated fatty acid...

  • Pharmacotherapy For Diabetic Retinopathy. Comer, Grant; Ciulla, Thomas A. // Review of Ophthalmology;Sep2004, Vol. 11 Issue 9, special section p25 

    Describes pharmacotherapy options for diabetic retinopathy (DR). Direct modulators such as vascular endothelial growth factors, protein kinase C inhibitors and pigment epithelium-derived factor inducers; Indirect modulators such as somatostatin, COX-2 inhibitors and antioxidants; Extracellular...

  • Blastocyst Brouhaha. Bailey, Ronald // Reason;Oct2001, Vol. 33 Issue 5, p25 

    Addresses the issues concerning embryonic stem cell research in the United States. Diseases which are potential for treatment by stem cells; Scientific explanation on how the stem cells may be of therapeutic use; Argument on the cloning issue related to the implementation of the research;...

  • Direct Reprogramming. Marbán, Eduardo; Cingolani, Eugenio // JAMA: Journal of the American Medical Association;7/7/2015, Vol. 314 Issue 1, p19 

    The authors comment on the direct reprogramming of stem cells for therapeutics. Topics covered include concerns that have restricted in vivo applications of tissues and organs to be recreated from embryonic stem cells, the limitations of induced stem cells as well as the complexity of...

  • Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema. Ozkurt, Yelda Buyru; Akkaya, Sezen; Aksoy, Sibel; Evciman, Tufan; Haboğlu, Melih; Haboğlu, Melih // Journal of Ocular Pharmacology & Therapeutics;Oct2015, Vol. 31 Issue 8, p455 

    Purpose: To evaluate and compare the efficacy of posterior subtenon's triamcinolone injections versus grid laser photocoagulation (GLP) combined with posterior subtenon's triamcinolone injection in eyes with diabetic macular edema (DME).Methods: In this prospective...

  • Early Success Reported in hESC Trial for Macular Degeneration. Moran, Nuala // BioWorld International;1/25/2012, Vol. 17 Issue 4, p1 

    The article reports on the early signs of efficacy of the human embryonic stem cell (hESC)-derived retinal pigment epithelium cells in treating macular degeneration, according to the hESC trial of Advanced Cell Technology (ACT) Inc. in Europe. The patients who suffered from severe vision loss...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics